Richard has advised research institutions and companies of all sizes, from innovative start-ups to large multinationals, and in sectors including telecommunications, software, security, medical services, and financial services to name but a few. For start-ups and SMEs, Richard has helped to define and develop bespoke intellectual property strategies in order to assist clients in best practice management of their patents, trade secrets and designs.
Richard has amassed experience in handling IP matters across a wide range of technologies, although has particularly focussed on the areas of physics, electronics, and software. He has particular experience drafting and prosecuting patent applications concerning:
-Quantum technologies, including quantum computing, quantum cryptography, quantum algorithms and quantum metrology
-Machine learning, particularly using neural networks and/or random forests
-Blockchain technologies, including both novel blockchain architectures and novel blockchain implementations with smart contracts
-Telecommunications, including standards essential patents, user interfaces, network communications and messaging protocols
-Cryptography, including position verification protocols and public key protocols such as elliptic curve cryptography
-Medical devices, particularly in relation to blood analyte sensors and radiopharmaceutical imaging.
Richard is a true philomath, logophile and puzzle enthusiast who takes a keen interest in cutting edge technologies, particularly if there is interesting mathematics or physics behind the curtain. As such, Richard is well suited for the technical disputes and logomachies required to obtain and maintain an effective intellectual property portfolio.
Natural Sciences (Physics, Mathematics, Philosophy), Durham University, 2008
Theoretical Physics, University of St Andrews, 2012
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.